Associate Director, R&D Asset Transition & Integration Office (RATIO)

Takeda Pharmaceutical Co.; Warszawa; Hybrid; PLN 300.000 - 460.000; Vollzeit

Zusammenfassung

Takeda Pharmaceutical Co. is seeking an Associate Director to join the R&D Asset Transition and Integration Office in Warsaw.

You will lead end-to-end transitions across integrations, in-licensing, wind-downs, divestments, and externalizations, coordinating with external partners and internal R&D functions to ensure a compliant, timely close. You will operate at the intersection of science, operations, and strategy, bringing structure to complex transitions while upholding data integrity and

Qualifikationen

• Minimum bachelor’s degree in a scientific or related field; an advanced degree is welcome.
• Fluent English for global governance forums.
• Strong communication and interpersonal skills; ability to navigate ambiguity.

Aufgaben

• Support or selectively lead assigned R&D asset transitions, defining scope, sequencing, critical path, and end state.
• Translate contracts and transition plans into clear operational work plans with named owners and dates.
• Act as the operational contact with external partners, licensors, buyers, and vendors; coordinate scheduling and decisions.
• Coordinate delivery across Regulatory Affairs, Pharmacovigilance, Clinical Operations, and other functions.
• Manage study closeout, regulatory withdrawal, and financial reconciliation.
• Establish and run governance cadence; brief senior leadership and external representatives.
• Execute transition activities such as data transfer, regulatory filing transitions, and vendor transitions.
• Identify and propose process improvements across the transition lifecycle.
• Share best practices and contribute to RATIO frameworks and playbooks.

Kenntnisse

Fluent English

Strong communication

Ability to navigate ambiguity

End-to-end ownership

Ausbildung

Bachelor’s degree in a scientific field

Advanced degree welcomed

Jobbeschreibung

Job Description

About the role:

At Takeda, we are guided by our purpose of Better Health for People, Brighter Future for the World and our commitment to patients, our people, and the planet. As we continue to evolve our portfolio through acquisitions, partnerships, and divestitures, the ability to transition and integrate assets seamlessly is essential to delivering on our commitments to patients, regulators, and partners.

We are seeking an Associate Director to join the R&D Asset Transition and Integration Office, the function responsible for executing R&D asset transitions across integrations, in-licensing, asset wind-downs, divestments, and externalizations. In this role, you will lead and support assigned transitions end to end, acting as the R&D execution and operational point of contact to external partners and counterparties, and driving delivery across the R&D functions to a clean, compliant close.

You will operate at the intersection of science, operations, and strategy, bringing structure to complex transitions while maintaining high standards of quality and data integrity.

How you will contribute:

• Support or selectively lead assigned R&D asset transitions, especially wind-downs or terminations and select post-trial commitments, defining scope, sequencing, critical path, resourcing, and target end state
• Translate contractual obligations, license agreements, transition plans, and post-term commitments into clear operational work plans with named owners and dates
• Act as the operational point of contact with external partners, licensors, buyers, and vendors, including on scheduling requirements, operational decisions, and contractual clarifications
• Coordinate delivery across Regulatory Affairs, Pharmacovigilance, Clinical Operations, Clinical Data Management, Biostatistics, Pharmaceutical Sciences, Nonclinical, Quality, Procurement, Legal, Finance, and Data and Technology
• Work with R&D functions to manage study closeout, sample and material disposition, regulatory withdrawal, trial transparency obligations, and financial reconciliation
• Establish and run the governance cadence for assigned transitions; elevate with clear recommendations and conduct briefings for senior leadership and external representatives
• Execute critical transition activities, such as data and records transfer, regulatory filing transitions, safety and pharmacovigilance handovers, system migrations and decommissioning, and contract and vendor transitions
• Anticipate operational and regulatory challenges across the transition lifecycle and recommend improvements to process and approach
• Serve as a best practice resource for the function, contributing to RATIO frameworks, playbooks, and tools, and applying lessons learned so each transition improves on the last

Minimum Requirements/Qualifications:

• Minimum bachelor’s degree in a scientific or related field; an advanced degree is welcome
• 8 or more years of relevant experience in the pharmaceutical or biotechnology industry, especially in R&D strategy and operations or program management
• Demonstrated end-to-end ownership of multi-functional programs
• Demonstrated delivery in global matrixed environments
• Working knowledge of R&D processes, such as clinical development, regulatory, safety, and quality systems, and how they interact during a transition
• Experience working with external counterparties such as partners, licensors, contract research organizations, or vendors
• Understanding of data and records management, such as regulatory data transfer, system transitions, and archival strategies
• Familiarity with global R&D systems and infrastructure, and how they interact during transitions
• Fluent English at a level suitable for global governance forums
• Preferred: experience in R&D alliance management, business development, for example mergers and acquisitions integration, divestment, in-licensing, R&D technology or sponsor transfer, asset termination, or life sciences strategy or management consulting
• Preferred: familiarity with regulatory filing transfers and with clinical, safety, and regulatory systems and their migration
• Preferred: contract literacy
• Preferred: budget forecasting, tracking, and closeout for program spend
• Preferred: experience working across cultures and time zones
• Strong communication and interpersonal skills, with the ability to help create a collaborative environment
• Ability to navigate ambiguity and keep progress moving in highly complex environments.

More about us:

At Takeda, we are transforming patient care through the development of novel specialty pharmaceuticals and best in class patient support programs. Takeda is a patient-focused company that will inspire and empower you to grow through life-changing work.

Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to people around the world.

This position is currently classified as "hybrid" following Takeda's Hybrid and Remote Work policy.

Locations

Warsaw, Poland

Worker Type

Employee

Worker Sub-Type

Regular

Time Type

Full time